1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Drug Eluting Stents Market
2.2. Global Drug Eluting Stents Market, By Product, 2023 (US$ Million)
2.3. Global Drug Eluting Stents Market, By Application, 2023 (US$ Million)
2.4. Global Drug Eluting Stents Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Drug Eluting Stents Market: Competitive Analysis
3.1. Market Positioning of Key Drug Eluting Stents Market Vendors
3.2. Strategies Adopted by Drug Eluting Stents Market Vendors
3.3. Key Industry Strategies 4. Drug Eluting Stents Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Drug Eluting Stents Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Polymer Based Coating
5.3.1.1. Non-Biodegradable Polymer Based
5.3.1.2. Biodegradable Polymer Based
5.3.2. Polymer Free Coating
5.3.2.1. Micro Porous Surface
5.3.2.2. Microstructured Surface
5.3.2.3. Slotted Tubular Surface
5.3.2.4. Nanoporous Surface
7. North America Drug Eluting Stents Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
7.3. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
7.4.Drug Eluting Stents Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
7.4.1.1.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
7.4.1.2.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
7.4.1.3.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8. UK and European Union Drug Eluting Stents Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.3. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8.4.Drug Eluting Stents Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.4.1.1.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.4.1.2.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.4.1.3.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.4.1.4.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.4.1.5.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
8.4.1.6.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9. Asia Pacific Drug Eluting Stents Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.3. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9.4.Drug Eluting Stents Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.4.1.1.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.4.1.2.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.4.1.3.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.4.1.4.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.4.1.5.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
9.4.1.6.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
10. Latin America Drug Eluting Stents Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
10.3. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
10.4.Drug Eluting Stents Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
10.4.1.1.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
10.4.1.2.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
10.4.1.3.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
11. Middle East and Africa Drug Eluting Stents Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
11.3. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
11.4.Drug Eluting Stents Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
11.4.1.1.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
11.4.1.2.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Drug Eluting Stents Market: By Product, 2022-2032, USD (Million)
11.4.1.3.2. Drug Eluting Stents Market: By Application, 2022-2032, USD (Million)
12. Company Profile
12.1. Abbott Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Biosensors International Group
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Biotronik
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Boston Scientific Corporation
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Cook Medical
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Lepu Medical Technology
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Medtronics Plc
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Terumo Medical Corporation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Shandong JW Medical Systems
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Stentys
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
